Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23237516.
- Also identified by DOI 10.1016/j.biomaterials.2012.11.040.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vascular occlusion can result in fatal myocardial infarction, stroke or loss of limb in peripheral arterial disease. Interventional balloon angioplasty is a common first line procedure for vascular disease treatment, but long term success is limited by restenosis and neointimal hyperplasia. Cellular therapies have been proposed to mitigate these issues; however efficacy is low, in part due to poor cell retention. We show that magnetic targeting of mesenchymal stem cells gives rise to a 6-fold increase in cell retention following balloon angioplasty in a rabbit model using a clinically applicable permanent magnet. Cells labelled with superparamagnetic iron oxide nanoparticles exhibit no negative effects on cell viability, differentiation or secretion patterns. The increase in stem cell retention leads to a reduction in restenosis three weeks after cell delivery.
Medical subject headings
- Dextrans
- Magnetite Nanoparticles
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
- Nanoparticles
- Vascular System Injuries